IN VITRO NEUROTECHNOLOGY
DefiningNeuro Translation.
/NEKS-EYE/
We build translational in vitro neural models that turn preclinical research into clinical insight — so the next generation of CNS therapies actually reach patients.
THE CRISIS
CNS therapeutics are facing a crisis of human relevance.
A translational bottleneck is keeping the most promising brain therapies from reaching patients. The root cause is simple: the models the industry bets on aren't human.
A translational bottleneck
Promising drug candidates stall before they ever reach patients — not for lack of ambition or capital, but because the science underneath doesn't carry over to humans.
Built on the wrong biology
Go/no-go decisions rely on animal models — primarily transgenic rodents engineered to imitate human brain disease. Mice aren't small humans, and their brains don't behave like ours.
A signal that doesn't hold
Investors and regulators need evidence that predicts the clinic. Animal data gives them confidence that too often evaporates the moment a candidate meets a human brain.
OUR APPROACH
Models that mirror human biology — not just human cells in a dish.
Existing technologies lack the adequate complexity and format to answer the questions about the brain's cognitive function. By combining patient-derived neural systems with functional electrophysiology, we generate the kind of clinically meaningful data the field has been missing.
See how it worksPartner with the next generation of neuroscience.
Programs are stalling due to a lack of human relevant data, we help by generating translational signal that builds conviction in your asset. Whether you're advancing a CNS program or exploring novel mechanisms, our team is ready to help.
Start a conversation